Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $5.6100 (-5.4%) ($5.5000 - $5.9200) on Thu. Aug. 27, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.32% (three month average) | RSI | 52 | Latest Price | $5.6100(-5.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -4.4% a day on average for past five trading days. | Weekly Trend | ANPC declines -4.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) IGOV(10%) IPO(10%) XLB(10%) LIT(9%) TLT(8%) | Factors Impacting ANPC price | ANPC will decline at least -4.16% in a week (0% probabilities). SHY(-28%) XLU(-11%) IBB(-9%) XBI(-8%) TBT(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.16% (StdDev 8.32%) | Hourly BBV | 1.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $6.45 | 5 Day Moving Average | $6.04(-7.12%) | 10 Day Moving Average | $6.51(-13.82%) | 20 Day Moving Average | $6.45(-13.02%) | To recent high | -28.5% | To recent low | 10.2% | Market Cap | $48m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |